General Info
Location: Grenzacherstrasse 124
Country: Switzerland
Industries:
Investment Regions: EU
Investment Stages:
Website: http://www.roche.com/venturefund.htm
corporate-vc
EU
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: active
AI Reasoning: Roche Venture Fund’s own news archive shows a portfolio/news item: COUR Pharmaceuticals Secures $105M Series A on January 30, 2024 and other investments through 2024; external sources (PitchBook) list a Roche Venture Fund investment on 15-Oct-2025 in Mission Therapeutics. The most recent known investment found is 15 October 2025 in Mission Therapeutics. From that date to the evaluation date is less than 3 months, indicating very recent activity falling into the ‘very-active’ range. The invested startup named is Mission Therapeutics.
Here are the thresholds established for the different statuses:
Not Active – No known investments in the last 12 months.
Low Activity – Only known investments between the last 12 and 6 months.
Active – Known investments between the last 6 and 3 months.
Very Active – Known investments in the last 3 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
Carole …
Head of Roche Venture Fund
David …
Investment Director
…
…
…
Warm Intros from Portfolio Companies
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Roche Venture Fund
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI